首页> 外文OA文献 >FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

【2h】

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

机译：FEC与序贯多西紫杉醇联合表柔比星/环磷酰胺作为腋窝淋巴结阳性早期乳腺癌妇女的辅助化疗：古希腊肿瘤研究组（HORG）的一项随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Polyzos, Aristides; Malamos, Nikolaos; Boukovinas, Ioannis; Adamou, Adamos; Ziras, Nikolaos; Kalbakis, Kostas; Kakolyris, Stylianos; Syrigos, Kostas; Papakotoulas, Pavlos; Kouroussis, Charalambos; Karvounis, Nikolaos; Vamvakas, Lambros; Christophyllakis, Charalambos; Athanasiadis, Athanasios; Varthalitis, Ioannis; Georgoulias, Vassilis; Mavroudis, Dimitris;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). [J] . Polyzos A, Malamos N, Boukovinas Breast cancer research and treatment. . 2010,第1期

机译：FEC与序贯多西紫杉醇联合表柔比星/环磷酰胺作为腋窝淋巴结阳性早期乳腺癌妇女的辅助化疗：希腊肿瘤研究小组（HORG）的一项随机研究。
2. FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) [J] . Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas, Breast Cancer Research and Treatment . 2010,第1期

机译：FEC与序贯多西紫杉醇联合表柔比星/环磷酰胺作为腋窝淋巴结阳性早期乳腺癌妇女的辅助化疗：希腊肿瘤研究组（HORG）的一项随机研究
3. Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG) [J] . Mavroudis D., Matikas A., Malamos N., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第10期

机译：HER2阴性，腋窝淋巴结阳性的早期乳腺癌妇女的剂量密集型FEC联合多西他赛与多西他赛加环磷酰胺作为辅助化疗：希腊肿瘤研究组（HORG）进行的多中心随机研究
4. Nanosecond pulsed electric fields adjuvant chemotherapy for breast cancer: An in vitro study [C] . Wu S., Guo J., Su B., IEEE Pulsed Power Conference . 2013

机译：纳秒脉冲电场辅助化疗对乳腺癌的体外研究
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk node-negative early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group [O] . Dimitrios Mavroudis, Emmanouil Saloustros, Ioannis Boukovinas, 2017

机译：序贯与并发表柔比星和多西紫杉醇作为高危淋巴结阴性早期乳腺癌的辅助化疗：来自希腊肿瘤研究组的一项随机III期研究的中期分析
7. Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG) [O] . D. Mavroudis, E. Saloustros, N. Malamos, 2020

机译：静脉静脉曲张与12个月的辅助曲妥珠单抗与Her2阳性乳腺癌的妇女组合组合：Hellenic肿瘤学研究组（Horg）的多中心随机研究

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅